On one hand I think it's great that ABL could potentially play a role in combating Covid-19.  That said the PR: a) made me wonder how connected RVX actually is in that they would need a PR to advertise their dominance in the epigenetics field; and, b) that it increased the likelihood that there are presently no discussions going on behind the scenes with a BP in terms of a buyout.  That is not to say that there isn't, I'm only saying that it now seems less likely.  However, discussions as to partnering arrangements are probably still in the works otherwise how can the company survive going forward?

I do agree with city that if the latebreaker was pulled that it wouldn't be because the presenter got sick.  I was being facetious when I posted that....not getting out enough these days I guess.  Who knows why it happened.